First subsequent treatment after discontinuation of durvalumab in unresectable, stage III NSCLC patients from PACIFIC.David Planchard,Byoung Chul Cho,Jhanelle Elaine Gray,Luis G. Paz-Ares,Mustafa Ozguroglu,Augusto E. Villegas,Davey B. Daniel,David Vicente,Shuji Murakami,Rina Hui,Takayasu Kurata,Alberto Chiappori,Ki Hyeong Lee,Maike De Wit, Yu Gu,Catherine Wadsworth,Phillip A. Dennis,Scott Joseph AntoniaONCOLOGY RESEARCH AND TREATMENT(2020)引用 26|浏览102暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要